Researchers in Prof. Crystal Mackall's laboratory at Stanford University are focused on translational research related to cancer immunotherapy, including basic T-cell function and tumor immunology.
Stanford researchers have developed a next-generation bead-based assay platform that enables highly scalable, multiplexed detection of proteins, antibodies and oligonucleotides in a single run.
Stanford scientists in Dr. Michael Lin's lab have established the use of B-cell reducing agents to improve an oncolytic virus (OV) therapy to rewire cancer signaling while limiting the production of antibodies against the virus in mouse studies.
Stanford researchers have developed a patented, wearable, haptic feedback device that provides position and velocity information on the limbs and torso by imparting rotational skin stretch.
Stanford researchers have developed flat, ultrathin (sub 100nm) optical elements based on high index nanostructures which can be alternatives to refractive optical elements such as gratings, lenses, and axicons.
Stanford researchers in the Vuckovic group have fabricated thin-film 4H crystal structure Silicon Carbide with excellent quantum and classical photonics properties.
Heart failure is a complex cardiovascular disease that affects 26 million people worldwide and is characterized by the inability of the heart to pump blood effectively, leading to a decline in its normal functions.
Researchers at Stanford have discovered a therapeutic strategy to overcome off-target red blood cell (RBC) toxicity associated with anti-CD47 antibody cancer therapies and possibly antibody-mediated autoimmune anemia and thrombocytopenia.
Stanford researchers have created an optimized stuffer sequence derived from the human BMP-10 3'UTR to enhance the packaging efficiency, productivity, and safety of recombinant adeno-associated virus (rAAV) vectors in gene therapy applications.
Stanford researchers have developed a novel, real-time biofeedback system that may help reduce pain for patients suffering from movement disorders such as osteoarthritis, patellofemoral pain syndrome, or stroke.
Stanford researchers have developed a method of reducing pulmonary hypertension (PH) in mammals by targeting FHIT (Fragile Histidine Triad), a gene not previously linked to PH but consistently reduced in blood of patients with pulmonary arterial hypertension (PAH).
Methane (CH4), a potent greenhouse gas with 25 times the thermal impact of carbon dioxide (CO2), contributes to about 30% of global warming since the Industrial Revolution.